(Press-News.org) BOSTON, MA - Use of antidepressants late in pregnancy has been controversial since the FDA issued a Public Health Advisory in 2006 warning that the use of antidepressants in late pregnancy may increase risk of persistent pulmonary hypertension of the newborn (PPHN), a condition that typically occurs in term or near-term infants and presents within hours of birth with severe respiratory failure requiring intubation and mechanical ventilation. The 2006 public health advisory was based on a single epidemiologic study that found a six-fold increase in risk associated with exposure to selective serotonin reuptake inhibitors (SSRI), commonly prescribed antidepressants, after the twentieth week of pregnancy. Based on a review of additional studies with conflicting findings, the FDA concluded in 2011 that it was premature to reach any conclusion about a possible link between SSRI use in pregnancy and PPHN, and updated the advisory accordingly.
Given the ongoing controversy regarding the association between SSRI exposure in late pregnancy and the risk of PPHN, researchers from Brigham and Women's Hospital (BWH) and the Harvard T.H. Chan School of Public Health examined the risk of PPHN associated with both SSRI and non-SSRI antidepressants in a large cohort of publicly insured pregnant women across the United States. In new findings published in JAMA on June 2, 2015, researchers demonstrate that while the possibility of an increased risk of PPHN associated with maternal use of antidepressants in late pregnancy cannot be entirely excluded, the absolute risk is small and the risk increase, if present, appears more modest than suggested in previous studies.
"Clinicians and patients need to balance the potential small increase in the risk of PPHN, along with other risks that have been attributed to SSRI use during pregnancy, with the benefits attributable to these drugs in improving maternal health and well being," said Krista Huybrechts, MS. PhD, corresponding author of the study and epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at BWH.
The cohort study included 3,789,330 pregnant women enrolled in Medicaid from two months or less after the date of last menstrual period through at least one month after delivery, of which 128,950, or 3.4 percent, filled at least one prescription for an antidepressant late in pregnancy. Among these women, 102,179 or 2.7 percent used an SSRI and 26,771 or 0.7 percent a non-SSRI antidepressant. The reference group consisted of women without exposure to antidepressants at any time during pregnancy.
Overall, 20.8 per 10,000 infants not exposed to antidepressants during the last 90 days of pregnancy had PPHN compared with 31.0 per 10,000 infants exposed to antidepressants. This higher risk among exposed infants was observed for both SSRI (31.5 per 10,000 infants) and non-SSRI (29.1 per 10,000 infants) antidepressants, representing a 40 to 50 percent increase in risk. After accounting for differences in the characteristics of women who did and did not take antidepressants, there was no longer a significant increase in the risk of PPHN associated with SSRI or non-SSRI antidepressants.
The findings in the largest cohort studied to date suggest that the risk of PPHN associated with late pregnancy exposure to SSRI antidepressants, if present, is smaller than previous studies have reported. Additionally, no evidence was found of a significantly increased risk associated with non-SSRI antidepressant medication use.
INFORMATION:
This research was supported by Agency for Healthcare Research and Quality (AHRQ) grant R01 HSO18533 and the National Institute of Mental Health grant K01MH099141.
An analysis of approximately 3.8 million pregnancies finds that use of antidepressants late in pregnancy may be associated with an increased risk of persistent pulmonary hypertension of the newborn (PPHN), according to a study in the June 2 issue of JAMA. However, the absolute risk was small and the risk increase appears more modest than suggested in previous studies. PPHN is a rare but life-threatening condition that occurs when a newborn's circulation system doesn't adapt to breathing outside the womb.
Persistent pulmonary hypertension of the newborn is associated with ...
Implementation of a pre-surgical intervention that included screening for the bacteria Staphylococcus aureus, treating patients who were positive for this bacteria, and the administration of antibiotics based on these culture results was associated with a modest reduction in S. aureus surgical site infections, according to a study in the June 2 issue of JAMA.
S. aureus carriage increases the risk of S. aureus surgical site infections (SSIs). The risk for these infections may be decreased by screening patients for nasal carriage of S. aureus and decolonizing carriers ...
An analysis of the use of computerized clinical decision support systems regarding orders for advanced diagnostic imaging found that the systems failed to identify relevant appropriateness criteria for the majority of orders, according to a study in the June 2 issue of JAMA.
Computerized clinical decision support (CDS) systems that match patient characteristics against appropriateness criteria to produce algorithmic treatment recommendations are a potential means of improving care. The Protecting Access to Medicare Act of 2014 mandates use of CDS systems for the ordering ...
Using tools that help physicians decide whether to use expensive imaging studies such as MRI scans can help reduce the ordering of unnecessary tests, but implementation of the tools in real-world settings has many challenges, according to a new RAND Corporation study.
The tools, computer-based programs that match a patient's characteristics against treatment criteria and recommend a treatment, helped increase the proportion of tests for Medicare fee-for-service patients rated as appropriate, according to findings published in the June 2 edition of the Journal of the American ...
This news release is available in French. Montreal, June 2nd, 2015 - A team of researchers from Universite de Montreal, Polytechnique Montreal and the Centre national de la recherche scientifique (CNRS) in France is the first to succeed in preventing two-dimensional layers of black phosphorus from oxidating. In so doing, they have opened the doors to exploiting their striking properties in a number of electronic and optoelectronic devices. The study's results were published in the prestigious journal Nature Materials.
Black phosphorus: future key player in new technologies
Black ...
Any box or bottle of over-the-counter (OTC) medicine lists its active ingredients prominently on the label. But are consumers using that information to make wise choices about taking two or more OTC drugs at the same time? Probably not, suggests a new study in the Journal of Public Policy & Marketing.
"A consumer who takes a cold medicine containing, for instance, acetaminophen, may see nothing wrong with taking an additional medicine that also contains acetaminophen," write authors Jesse R. Catlin (California State University, Sacramento), Connie Pechmann (University ...
You go to the grocery store to buy a pound of ground beef and a can of tomato sauce. You walk out with the ground beef, the sauce, and a bag of chocolate-covered almonds, a silicon spatula, and the latest celebrity magazine. What happened? According to a new study in the Journal of Marketing, what and when you purchased determined the array of items you eventually bought.
"Shoppers enter the grocery store planning to buy certain things, but are tempted to buy unplanned items," write authors Timothy J. Gilbride (University of Notre Dame), Jeffrey Inman (University of Pittsburgh), ...
Consumers often complain that online companies violate their privacy--but the problem may be with the consumers themselves. According to a new study in the Journal of Public Policy & Marketing, there can be a big discrepancy between what consumers believe that online privacy policies promise and what those policies do in fact promise. Many consumers assume policy protections that were never there.
"The difference between the level of privacy consumers think they have after reading a privacy notice and the level of privacy they actually have can be striking," writes the ...
A new study by a University of Toronto Mississauga researcher has taken the first-ever look at the academic outcomes of children with epilepsy who have had brain surgery, and found that they have a higher chance of struggling in class following their surgery.
Psychology professor Mary Lou Smith was co-leader of a team of researchers who studied the arithmetic, spelling, reading and reading comprehension abilities of children after having resective epilepsy surgery, a procedure that involves removing a part of the brain in order to halt seizures. The patients completed ...
Not too long ago, Microsoft mailed loyal Xbox customers an e-card encoded with twenty-five cents' worth of Microsoft points. The software behemoth might have thought it was showing appreciation. But recipients of the company's "generosity" might have felt "Is that all I'm worth?" According to a new study in the Journal of Marketing, companies that bestow monetary gifts in too small amounts can leave customers feeling, well, small.
"Financial acknowledgments, if they are too insignificant, can definitely backfire," write authors Peggy J. Liu (Duke University), Cait Lamberton ...
